What's in Shijiazhuang Yiling Pharmaceutical Co. Ltd's pipeline?

Shijiazhuang Yiling Pharmaceutical Co. Ltd has 6 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 3 in Phase 1.

Which companies overlap with Shijiazhuang Yiling Pharmaceutical Co. Ltd's portfolio?

Top competitors by shared drug class: Ain Shams University, Takeda, Pfizer, AJU Pharm Co., Ltd., AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/shijiazhuang-yiling-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Shijiazhuang Yiling Pharmaceutical Co. Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shijiazhuang Yiling Pharmaceutical Co. Ltd pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Felbinac Trometamol Injection	Felbinac Trometamol Injection	phase 3	Non-steroidal anti-inflammatory drug (NSAID)	Cyclooxygenase (COX-1 and COX-2)	Pain Management / Rheumatology
XY0206	XY0206	phase 3	SGLT2 inhibitor	SGLT2	Diabetes

Therapeutic area mix

Diabetes · 1
Other · 1
Pain Management / Rheumatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams University · 2 shared drug classes
Takeda · 2 shared drug classes
Pfizer · 2 shared drug classes
AJU Pharm Co., Ltd. · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Abbott · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Shijiazhuang Yiling Pharmaceutical Co. Ltd:

Cite this brief

Drug Landscape (2026). Shijiazhuang Yiling Pharmaceutical Co. Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shijiazhuang-yiling-pharmaceutical-co-ltd. Accessed 2026-05-16.